Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The influence of the CYP3A4*22 polymorphism on serum concentration of quetiapine in psychiatric patients.

Journal of clinical psychopharmacology - 1 Apr 2014

van der Weide Karen, van der Weide Jan

Abstract excerpt

BACKGROUND: Besides dietary, hormonal, or pathological factors, mutations in cytochrome P450 enzymes are thought to be responsible for the interindividual differences in serum concentrations of cytochrome P450 (CYP450)-dependent drugs. Cytochrome P450 3A4 (CYP3A4) is involved in the metabolism of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antipsychotic Agents
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP3A

Share to Heterozygote

Share to Mental Disorders

Share to Netherlands

Share to Young Adult

Source

Identifiers

PMID: 24525658
DOI: 10.1097/JCP.0000000000000070

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24525658-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The influence of the CYP3A4*22 polymorphism on serum concentration of quetiapine in psychiatric patients.PMID 24525658Read ↗

The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.Semantic proximity Read ↗

The Pharmacogenetics of Treatment with QuetiapineSemantic proximity Read ↗

Genetic and Clinical Factors Affecting Plasma Clozapine ConcentrationSemantic proximity Read ↗

Effect of CYP3A5*3 genotype on exposure and efficacy of quetiapine: A retrospective, cohort study.Semantic proximity Read ↗

Investigation of CYP3A4*22 polymorphism effects on the depressed treatment by citalopram and sertralineSemantic proximity Read ↗

Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers.Semantic proximity Read ↗

Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.Semantic proximity Read ↗

ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.Semantic proximity Read ↗

Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.Semantic proximity Read ↗

Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder.Semantic proximity Read ↗

ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.Semantic proximity Read ↗

MDR-1 genotypes and quetiapine pharmacokinetics in healthy volunteers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.